Kopp Family Office, LLC
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed April 20, 2026), Kopp Family Office, LLC reported 21 stock positions worth $145.3 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 19.4% of the portfolio, followed by iShares Core U.S. Aggregate (AGG, 18.8%) and Invesco S&P 500 Equal Weight (RSP, 14.0%). Compared with Q4 2025, it opened 1 new position, sold out of 1, added to 2 and reduced 10. The biggest buy was a new position in SS SPDR S&P 500 ETF Trust-US (SPY) and the biggest sale iShares Core S&P Midcap ETF (IJH, shares −50%).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $145.3M (Q1 2026)
- SEC Filing
- 0000892712-26-000219 ↗ filed Apr 20, 2026
Holdings Value
Holdings 21 stocks · $145.3M
| VEA Vanguard Ftse Developed ETF | 19.39% | 439,867 | $28.2M | Reduce -6.1% |
| AGG iShares Core U.S. Aggregate | 18.80% | 275,258 | $27.3M | Add +58.8% |
| RSP Invesco S&P 500 Equal Weight | 13.96% | 105,688 | $20.3M | Reduce -1.7% |
| SPY SS SPDR S&P 500 ETF Trust-US | 13.37% | 29,889 | $19.4M | New |
| VWO Vanguard Ftse Emerging Marke | 8.41% | 226,058 | $12.2M | Reduce -31.1% |
| IJH iShares Core S&P Midcap ETF | 6.43% | 138,396 | $9.3M | Reduce -50.3% |
| VCEL Vericel Corp. | 3.62% | 163,355 | $5.3M | Add +1.1% |
| HWKN Hawkins Inc. | 2.85% | 26,957 | $4.1M | Reduce -1.2% |
| ATEC Alphatec Holdings Inc. | 2.46% | 328,680 | $3.6M | No change |
| WK Workiva Inc. | 2.29% | 55,866 | $3.3M | No change |
| XMTR Xometry Inc. Class A | 2.04% | 72,440 | $3.0M | Reduce -39.1% |
| TCMD Tactile Systems Technology I | 1.53% | 85,009 | $2.2M | Reduce -33.2% |
| MANH Manhattan Associates Inc. | 1.50% | 16,330 | $2.2M | No change |
| MSFT Microsoft Corp. | 1.27% | 4,981 | $1.8M | Reduce -41.2% |
| NTNX Nutanix Inc. Class A | 1.14% | 43,448 | $1.7M | Reduce -50.6% |
| VRDN Viridian Therapeutics Inc. | 0.74% | 55,295 | $1.1M | Reduce -68.1% |
| ISTB iShares Core 1-5 Year Usd Bo | 0.07% | 2,173 | $105K | No change |
| IVV iShares Core S&P 500 ETF | 0.07% | 147 | $96K | No change |
| IAGG iShares Intl Aggregate Bond | 0.03% | 839 | $42K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.03% | 911 | $40K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 141 | $18K | No change |
Portfolio Sells Q4 2025 → Q1 2026
| IJH iShares Core S&P Midcap ETF | Reduce -50.3% | 6.43% | −5.30 |
| VWO Vanguard Ftse Emerging Marke | Reduce -31.1% | 8.41% | −2.85 |
| VRDN Viridian Therapeutics Inc. | Reduce -68.1% | 0.74% | −2.70 |
| TEAM Atlassian Corp. Class A | Sold out | 0.00% | −2.61 |
| XMTR Xometry Inc. Class A | Reduce -39.1% | 2.04% | −2.48 |
| NTNX Nutanix Inc. Class A | Reduce -50.6% | 1.14% | −1.77 |
| MSFT Microsoft Corp. | Reduce -41.2% | 1.27% | −1.35 |
| TCMD Tactile Systems Technology I | Reduce -33.2% | 1.53% | −0.83 |
| HWKN Hawkins Inc. | Reduce -1.2% | 2.85% | +0.37 |
| VEA Vanguard Ftse Developed ETF | Reduce -6.1% | 19.39% | +0.71 |
| RSP Invesco S&P 500 Equal Weight | Reduce -1.7% | 13.96% | +0.81 |
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |